A GRK5 polymorphism that inhibits β-adrenergic receptor signaling is protective in heart failure (original) (raw)

• Levy, D. et al. Long-term trends in the incidence of and survival with heart failure. N. Engl. J. Med. 347, 1397–1402 (2002).
  Article PubMed Google Scholar
• Roger, V.L. et al. Trends in heart failure incidence and survival in a community-based population. J. Am. Med. Assoc. 292, 344–350 (2004).
  Article CAS Google Scholar
• Franz, W.M., Muller, O.J. & Katus, H.A. Cardiomyopathies: from genetics to the prospect of treatment. Lancet 358, 1627–1637 (2001).
  Article CAS PubMed Google Scholar
• The Merit HF Investigators. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353, 2001–2007 (1999).
• The β-Blocker Evaluation of Survival Trial Investigators. A trial of the β-blocker bucindolol in patients with advanced chronic heart failure. N. Engl. J. Med. 344, 1659–1667 (2001).
• van Campen, L.C., Visser, F.C. & Visser, C.A. Ejection fraction improvement by β-blocker treatment in patients with heart failure: an analysis of studies published in the literature. J. Cardiovasc. Pharmacol. 32 (suppl. 1), S31–S35 (1998).
  CAS PubMed Google Scholar
• Wagoner, L.E. et al. Polymorphisms of the β2-adrenergic receptor determine exercise capacity in patients with heart failure. Circ. Res. 86, 834–840 (2000).
  Article CAS PubMed Google Scholar
• Liggett, S.B. Pharmacogenetic applications of the Human Genome project. Nat. Med. 7, 281–283 (2001).
  Article CAS PubMed Google Scholar
• Kohout, T.A. & Lefkowitz, R.J. Regulation of G protein–coupled receptor kinases and arrestins during receptor desensitization. Mol. Pharmacol. 63, 9–18 (2003).
  Article CAS PubMed Google Scholar
• Koch, W.J. et al. Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a β ARK inhibitor. Science 268, 1350–1353 (1995).
  Article CAS PubMed Google Scholar
• Koch, W.J. Genetic and phenotypic targeting of β-adrenergic signaling in heart failure. Mol. Cell. Biochem. 263, 5–9 (2004).
  Article CAS PubMed Google Scholar
• Matkovich, S.J. et al. Cardiac-specific ablation of G protein–receptor kinase 2 redefines its roles in heart development and β-adrenergic signaling. Circ. Res. 99, 996–1003 (2006).
  Article CAS PubMed Google Scholar
• Premont, R.T., Koch, W.J., Inglese, J. & Lefkowitz, R.J. Identification, purification, and characterization of GRK5, a member of the family of G protein–coupled receptor kinases. J. Biol. Chem. 269, 6832–6841 (1994).
  CAS PubMed Google Scholar
• Gainetdinov, R.R. et al. Muscarinic supersensitivity and impaired receptor desensitization in G protein–coupled receptor kinase 5–deficient mice. Neuron 24, 1029–1036 (1999).
  Article CAS PubMed Google Scholar
• Chen, E.P., Bittner, H.B., Akhter, S.A., Koch, W.J. & Davis, R.D. Myocardial function in hearts with transgenic overexpression of the G protein–coupled receptor kinase 5. Ann. Thorac. Surg. 71, 1320–1324 (2001).
  Article CAS PubMed Google Scholar
• Rockman, H.A. et al. Receptor-specific in vivo desensitization by the G protein–coupled receptor kinase-5 in transgenic mice. Proc. Natl. Acad. Sci. USA 93, 9954–9959 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Ungerer, M., Bohm, M., Elce, J.S., Erdmann, E. & Lohse, M.J. Altered expression of β-adrenergic receptor kinase and β1-adrenergic receptors in the failing human heart. Circulation 87, 454–463 (1993).
  Article CAS PubMed Google Scholar
• Ungerer, M. et al. Expression of β-arrestins and β-adrenergic receptor kinases in the failing human heart. Circ. Res. 74, 206–213 (1994).
  Article CAS PubMed Google Scholar
• Oyama, N. et al. Angiotensin converting enzyme inhibitors attenuated the expression of G protein–coupled receptor kinases in heart failure patients. Circ. J. 70, 362–363 (2006).
  Article CAS PubMed Google Scholar
• Dzimiri, N., Basco, C., Moorji, A., Afrane, B. & Al Halees, Z. Characterization of lymphocyte β2-adrenoceptor signalling in patients with left ventricular volume overload disease. Clin. Exp. Pharmacol. Physiol. 29, 181–188 (2002).
  Article CAS PubMed Google Scholar
• Liggett, S.B. et al. Early and delayed consequences of β2-adrenergic receptor overexpression in mouse hearts: critical role for expression level. Circulation 101, 1707–1714 (2000).
  Article CAS PubMed Google Scholar
• Asai, K. et al. β-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic Gsα mouse. J. Clin. Invest. 104, 551–558 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Okumura, S. et al. Disruption of type 5 adenylyl cyclase gene preserves cardiac function against pressure overload. Proc. Natl. Acad. Sci. USA 100, 9986–9990 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Bristow, M.R. β-adrenergic receptor blockade in chronic heart failure. Circulation 101, 558–569 (2000).
  Article CAS PubMed Google Scholar
• Packer, M. Current role of β-adrenergic blockers in the management of chronic heart failure. Am. J. Med. 110 (suppl. 7A), 81S–94S (2001).
  Article PubMed Google Scholar
• Waagstein, F. et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet 342, 1441–1446 (1993).
  Article CAS PubMed Google Scholar
• Liggett, S.B. et al. A polymorphism within a conserved β1-adrenergic receptor motif alters cardiac function and β-blocker response in human heart failure. Proc. Natl. Acad. Sci. USA 103, 11288–11293 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Small, K.M., Wagoner, L.E., Levin, A.M., Kardia, S.L. & Liggett, S.B. Synergistic polymorphisms of β1- and α2C-adrenergic receptors and the risk of congestive heart failure. N. Engl. J. Med. 347, 1135–1142 (2002).
  Article CAS PubMed Google Scholar
• Barnholtz-Sloan, J.S., Chakraborty, R., Sellers, T.A. & Schwartz, A.G. Examining population stratification via individual ancestry estimates versus self-reported race. Cancer Epidemiol. Biomarkers Prev. 14, 1545–1551 (2005).
  Article PubMed Google Scholar
• Pritchard, J.K., Stephens, M. & Donnelly, P. Inference of population structure using multilocus genotype data. Genetics 155, 945–959 (2000).
  CAS PubMed PubMed Central Google Scholar
• Bechhoffer, R.E., Kiefer, J. & Sobel, M. Sequential Identification and Ranking Procedures (University of Chicago Press, Chicago, 1986).
  Google Scholar
• Liggett, S.B. β-adrenergic receptors in the failing heart: the good, the bad, and the unknown. J. Clin. Invest. 107, 947–948 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Lloyd-Jones, D.M. et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 106, 3068–3072 (2002).
  Article PubMed Google Scholar
• Thom, T. et al. Heart disease and stroke statistics—2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113, e85–e151 (2006).
  PubMed Google Scholar
• Kim, J. et al. Functional antagonism of different G protein–coupled receptor kinases for β-arrestin–mediated angiotensin II receptor signaling. Proc. Natl. Acad. Sci. USA 102, 1442–1447 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Port, J.D. & Bristow, M.R. Altered β-adrenergic receptor gene regulation and signaling in chronic heart failure. J. Mol. Cell. Cardiol. 33, 887–905 (2001).
  Article CAS PubMed Google Scholar
• Cohn, J.N. et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N. Engl. J. Med. 311, 819–823 (1984).
  Article CAS PubMed Google Scholar
• Bristow, M.R. Why does the myocardium fail? Insights from basic science. Lancet 352 (suppl. 1), SI8–SI14 (1998).
  Article PubMed Google Scholar
• Shekelle, P.G. et al. Efficacy of angiotensin-converting enzyme inhibitors and β-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials. J. Am. Coll. Cardiol. 41, 1529–1538 (2003).
  Article CAS PubMed Google Scholar
• Liggett, S.B. et al. Altered patterns of agonist-stimulated cAMP accumulation in cells expressing mutant β2-adrenergic receptors lacking phosphorylation sites. Mol. Pharmacol. 36, 641–646 (1989).
  CAS PubMed Google Scholar
• D'Angelo, D.D. et al. Transgenic Galphaq overexpression induces cardiac contractile failure in mice. Proc. Natl. Acad. Sci. USA 94, 8121–8126 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Koch, W.J., Inglese, J., Stone, W.C. & Lefkowitz, R.J. The binding site for the βγ subunits of heterotrimeric G proteins on th eβ-adrenergic receptor kinase. J. Biol. Chem. 268, 8256–60 (1993).
  CAS PubMed Google Scholar
• Odley, A. et al. Regulation of cardiac contractility by Rab4-modulated β2-adrenergic receptor recycling. Proc. Natl. Acad. Sci. USA 101, 7082–7087 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Kaplan, E.L. & Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53, 457–481 (1958).
  Article Google Scholar
• Parmar, M. & Machin, D. Survival Analysis: A Practical Approach 115–142 (Wiley, New York, 1995).
  Google Scholar
• Lynch, M. & Walsh, B. Genetics and Analysis of Quantitative Traits 51–80 (Sinauer Associates, Sunderland, Massachusetts, 1998).
  Google Scholar
• Province, M.A. A single, sequential, genome-wide test to identify simultaneously all promising areas in a linkage scan. Genet. Epidemiol. 19, 301–322 (2000).
  Article CAS PubMed Google Scholar
• Cox, D.R. & Snell, E.J. Analysis of Binary Data 208–209 (Chapman & Hall, London, 1989).
  Google Scholar